Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MediXall (MDXL) Depreciation and Depletion (2020 - 2022)

MediXall's Depreciation and Depletion history spans 3 years, with the latest figure at $1379.0 for Q4 2022.

  • For Q4 2022, Depreciation and Depletion rose 761.88% year-over-year to $1379.0; the TTM value through Dec 2022 reached $3000.0, down 25.0%, while the annual FY2022 figure was $3000.0, 25.0% down from the prior year.
  • Depreciation and Depletion reached $1379.0 in Q4 2022 per MDXL's latest filing, up from -$2059.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $2680.0 in Q1 2022 to a low of -$2059.0 in Q3 2022.
  • Average Depreciation and Depletion over 3 years is $916.67, with a median of $1000.0 recorded in 2020.
  • The largest YoY upside for Depreciation and Depletion was 761.88% in 2022 against a maximum downside of 305.9% in 2022.
  • A 3-year view of Depreciation and Depletion shows it stood at $1000.0 in 2020, then tumbled by 84.0% to $160.0 in 2021, then skyrocketed by 761.88% to $1379.0 in 2022.
  • Per Business Quant, the three most recent readings for MDXL's Depreciation and Depletion are $1379.0 (Q4 2022), -$2059.0 (Q3 2022), and $1000.0 (Q2 2022).